Akebia Therapeutics, Inc. 10-Q filing
Filed 2025-08-07 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001628280-25-038600
- Form type
- 10-Q
- CIK
- 0001517022
- Primary document
- https://www.sec.gov/Archives/edgar/data/1517022/000162828025038600/akba-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Akebia Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $119.8M | - | - |
| Cost Of Revenue | $17.5M | - | - |
| Operating Income | $27.6M | - | - |
| Net Income | $6.4M | - | - |
| Eps Basic | 0.03 | - | - |
| Eps Diluted | 0.02 | - | - |
| Cash And Equivalents | $137.3M | - | - |
| Total Assets | $345.6M | - | - |
| Total Liabilities | $316.4M | - | - |
| Shareholders Equity | $29.2M | - | - |
| Operating Cash Flow | $8.8M | - | - |
| Capital Expenditures | $144,000 | - | - |